Below are the financial statements of Teva Pharmaceutical Industries, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 2024-01-01 - 2024-12-31 | 2023 2023-01-01 - 2023-12-31 | 2022 2022-01-01 - 2022-12-31 |
|---|---|---|---|
| Net revenues | 16,544a | 15,846a | 14,925a |
| Cost of sales | -8,481a | -8,200a | -7,952a |
| Gross profit | 8,064a | 7,645a | 6,973a |
| Research and development expenses, net | -998a | -953a | -838a |
| Selling and marketing expenses | -2,541a | -2,336a | -2,265a |
| General and administrative expenses | -1,161a | -1,162a | -1,180a |
| Intangible assets impairments | -251a | -350a | -355a |
| Goodwill impairment | -1,280a | -700a | -2,045a |
| Other asset impairments, restructuring and other items | -1,388a | -718a | -512a |
| Legal settlements and loss contingencies | -761a | -1,043a | -2,082a |
| Other loss (income) | -14a | -49a | -107a |
| Operating income (loss) | -303a | 433a | -2,197a |
| Financial expenses - net | -981a | -1,057a | -966a |
| Income (loss) before income taxes | -1,284a | -624a | -3,163a |
| Income taxes (benefit) | -676a | -7a | -643a |
| Share in (profits) losses of associated companies - net | -1a | -2a | -21a |
| Net income (loss) | -1,959a | -615a | -2,499a |
| Net income (loss) attributable to non-controlling interests | -320a | -56a | -53a |
| Net income (loss) attributable to Teva | -1,639a | -559a | -2,446a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Teva Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.